📰 Nasdaq First News
Page 13 - Nasdaq First News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq First. Real-time updates on events, politics, business and more.
September 22, 2023
TURKU, Finland and BOSTON, Sept. 22, 2023 -- Faron Pharmaceuticals Ltd , a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, announces that the...
September 22, 2023
TURKU, Finland and BOSTON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage...
August 29, 2023
/PRNewswire/ -- Trivet Medical LLC is a specialized strategic sales and distribution LLC, highly focused on commercializing disruptive, best-in-class med-tech...
August 29, 2023
Faron Pharmaceuticals Ltd. Inside Information: Faron Receives FDA Orphan Drug Designation for Bexmarilimab in Acute Myeloid Leukemia ODD further strengthens bexmarilimab program...
August 16, 2023
/PRNewswire/ -- Veterans Healthcare Supply Solutions (VHSS) has over 30 years of healthcare distribution management experience and represents leading...
August 9, 2023
DelfinGroup Half Year financial report Revenue of DelfinGroup grew by 52% in the second quarter The Latvian fintech company DelfinGroup continued to show...
July 19, 2023
TURKU, Finland and BOSTON, July 19, 2023 (GLOBE NEWSWIRE) -- Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage...
July 19, 2023
TURKU, Finland and BOSTON, July 19, 2023 (GLOBE NEWSWIRE) -- Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, will hold a conference call today to discuss new positive clinical data from the Company's ongoing Phase I/II BEXMAB study. Conference Call and Webcast Wednesday, July 19, 2023, at 8:30 am ET. The live call may be accessed by dialing (877) 407-3982 for callers in the US and (...
July 19, 2023
19.07.2023 - NEW YORK, July 19, 2023 (GLOBE NEWSWIRE) - Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the second quarter of 2023. Second quarter 2023 net revenues1 increased 4% compared to the second quarter of 2022. Solutions ...
June 14, 2023
PRESS RELEASE, Värnamo 14 June 2023 Bufab has appointed Pär Ihrskog as Chief Financial Officer . He will take up his position on August 14, 2023. Pär Ihrskog... | June 14, 2023